| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_707cb8964f106d9c48985a48184df25a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| filingDate |
2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cfa6da92f7587b24582cecde0a66ff3 |
| publicationDate |
2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015104668-A2 |
| titleOfInvention |
Lyophilized formulations for parenteral use |
| abstract |
Lyophilized formulations comprising at least a derivative of rifamycin such as Rifabutin for parenteral use, and methods of preparation and administration thereof |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7339997-B2 |
| priorityDate |
2014-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |